Applying Mode-of-Action and Pharmacokinetic Considerations in Contemporary Cancer Risk Assessments: An Example with Trichloroethylene

ABSTRACT The guidelines for carcinogen risk assessment recently proposed by the U.S. Environmental Protection Agency (U.S. EPA) provide an increased opportunity for the consideration of pharmacokinetic and mechanistic data in the risk assessment process. However, the greater flexibility of the new guidelines can also make their actual implementation for a particular chemical highly problematic. To illuminate the process of performing a cancer risk assessment under the new guidelines, the rationale for a state-of-the-science risk assessment for trichloroethylene (TCE) is presented. For TCE, there is evidence of increased cell proliferation due to receptor interaction or cytotoxicity in every instance in which tumors are observed, and most tumors represent an increase in the incidence of a commonly observed, species-specific lesion. A physiologically based pharmacokinetic (PBPK) model was applied to estimate target tissue doses for the three principal animal tumors associated with TCE exposure: liver, lung, and kidney. The lowest points of departure (lower bound estimates of the exposure associated with 10% tumor incidence) for lifetime human exposure to TCE were obtained for mouse liver tumors, assuming a mode of action primarily involving the mitogenicity of the metabolite trichloroacetic acid (TCA). The associated linear unit risk estimates for mouse liver tumors are 1.5 × 10−6 for lifetime exposure to 1 μg TCE per cubic meter in air and 0.4 × 10−6 for lifetime exposure to 1 μg TCE per liter in drinking water. However, these risk estimates ignore the evidence that the human is likely to be much less responsive than the mouse to the carcinogenic effects of TCA in the liver and that the carcinogenic effects of TCE are unlikely to occur at low environmental exposures. Based on consideration of the most plausible carcinogenic modes of action of TCE, a margin-of-exposure (MOE) approach would appear to be more appropriate. Applying an MOE of 1000, environmental exposures below 66 μg TCE per cubic meter in air and 265 μg TCE per liter in drinking water are considered unlikely to present a carcinogenic hazard to human health.

[1]  Lock Ea Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes. , 1988 .

[2]  C. Mitoma,et al.  Metabolic disposition study of chlorinated hydrocarbons in rats and mice. , 1985, Drug and chemical toxicology.

[3]  D. Hathway Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice. , 1980, Cancer letters.

[4]  J. Foster,et al.  Trichloroethylene-induced mouse lung tumors: studies of the mode of action and comparisons between species. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[5]  D Hattis,et al.  Uncertainties in pharmacokinetic modeling for perchloroethylene. I. Comparison of model structure, parameters, and predictions for low-dose metabolism rates for models derived by different authors. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[6]  W. Dekant,et al.  Metabolism of trichloroethene--in vivo and in vitro evidence for activation by glutathione conjugation. , 1990, Chemico-biological interactions.

[7]  M. A. Pereira,et al.  The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. , 1987, Toxicology and applied pharmacology.

[8]  T. Goldsworthy,et al.  Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. , 1992, Carcinogenesis.

[9]  L. Lash,et al.  Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[10]  G. Olson,et al.  Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse☆ , 1992 .

[11]  J. Fuscoe,et al.  In vivo genotoxicity of dichloroacetic acid: Evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay , 1996, Environmental and molecular mutagenesis.

[12]  O. Raaschou-Nielsen,et al.  Cancer Incidence Among Danish Workers Exposed to Trichloroethylene , 2001, Journal of occupational and environmental medicine.

[13]  R. Bull Carcinogenic and mutagenic properties of chemicals in drinking water. , 1985, The Science of the total environment.

[14]  B C Allen,et al.  Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[15]  Michael A. Pereira Carcinogenic Activity of Dichloroacetic Acid and Trichloroacetic Acid in the Liver of Female B6C3F1 Mice , 1996 .

[16]  R. Cattley,et al.  Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.

[17]  D. Stevens,et al.  Metabolism of bromodichloroacetate in B6C3F1 mice. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[18]  G. Olson,et al.  Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[19]  J. Lipscomb,et al.  Glutathione conjugation of trichloroethylene in human liver and kidney: kinetics and individual variation. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[20]  D Hattis,et al.  Uncertainties in pharmacokinetic modeling for perchloroethylene: II. Comparison of model predictions with data for a variety of different parameters. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[21]  S. Ohmori,et al.  Metabolism of trichloroethylene. , 1980, Biochemical pharmacology.

[22]  M. A. Pereira,et al.  Promotion by mixtures of dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. , 1997, Cancer letters.

[23]  H J Clewell,et al.  Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. , 2000, Environmental health perspectives.

[24]  B. Thrall,et al.  Contribution of dichloroacetate and trichloroacetate to liver tumor induction in mice by trichloroethylene. , 2002, Toxicology and applied pharmacology.

[25]  M. Abdel‐Rahman,et al.  Toxicity and metabolism of trichloroethylene in rat hepatocytes , 1989, Archives of environmental contamination and toxicology.

[26]  M. Andersen,et al.  Physiologically based pharmacokinetic analyses of simple mixtures. , 1994, Environmental health perspectives.

[27]  W. Stott Chemically induced proliferation of peroxisomes: implications for risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.

[28]  M E Andersen,et al.  Dioxin hepatic carcinogenesis: biologically motivated modeling and risk assessment. , 1993, Toxicology letters.

[29]  C J Portier,et al.  Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[30]  A. Deangelo,et al.  Analysis of DNA strand breaks induced in rodent liver in vivo, hepatocytes in primary culture, and a human cell line by chlorinated acetic acids and chlorinated acetaldehydes , 1992, Environmental and molecular mutagenesis.

[31]  Reddy Jk,et al.  Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .

[32]  M. W. Anders,et al.  Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. , 1998, Chemical research in toxicology.

[33]  J. H. Carter,et al.  Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acid. , 1995, Toxicology letters.

[34]  K. Griffin,et al.  Peroxisome proliferator activated receptor-alpha expression in human liver. , 1998, Molecular pharmacology.

[35]  W. Dekant,et al.  Renal cell cancer correlated with occupational exposure to trichloroethene , 1998, Journal of Cancer Research and Clinical Oncology.

[36]  J. Popp,et al.  Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[37]  J. Groopman,et al.  Molecular Dosimetry and Human Cancer: Analytical, Epidemiological, and Social Considerations , 1991 .

[38]  M. Andersen,et al.  Negative selection in hepatic tumor promotion in relation to cancer risk assessment. , 1995, Toxicology.

[39]  L. Gold,et al.  Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points. , 1997, Regulatory toxicology and pharmacology : RTP.

[40]  P. G. Wells,et al.  Metabolic effects and pharmacokinetics of intravenously administered dichloroacetate in humans , 1980, Diabetologia.

[41]  D. Henschler,et al.  Trichloroethylene exposure and trichloroethylene metabolites in urine and blood , 2004, Archiv für Toxikologie.

[42]  T. Nakajima,et al.  Morphological and biochemical analyses of trichloroethylene hepatotoxicity: differences in ethanol- and phenobarbital-pretreated rats. , 1991, Toxicology and applied pharmacology.

[43]  L. Tuxen,et al.  Integrated risk information system (IRIS) , 1990 .

[44]  R H Reitz,et al.  In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models. , 1989, Toxicology and applied pharmacology.

[45]  J. Opdam,et al.  A method for the retrospective estimation of the individual respiratory intake of a highly and a poorly metabolising solvent during rest and physical exercise. , 1989, British journal of industrial medicine.

[46]  T. Nakajima,et al.  A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. , 1977, British journal of industrial medicine.

[47]  F. Korte,et al.  Comparative metabolism of [14C] trichloroethylene in chimpanzees, baboons, and rhesus monkeys , 1982 .

[48]  J. Powell,et al.  The excretion of sodium trichloracetate. , 1945, The Journal of pharmacology and experimental therapeutics.

[49]  H. Yamazaki,et al.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.

[50]  T. Brüning,et al.  Acute intoxication with trichloroethene: clinical symptoms, toxicokinetics, metabolism, and development of biochemical parameters for renal damage. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  M. Andersen,et al.  Risk Assessment Extrapolations and Physiological Modeling , 1985, Toxicology and industrial health.

[52]  H. Vainio,et al.  Sex-, age- and pregnancy-induced changes in the metabolism of toluene and trichloroethylene in rat liver in relation to the regulation of cytochrome P450IIE1 and P450IIC11 content. , 1992, The Journal of pharmacology and experimental therapeutics.

[53]  Adduction of hemoglobin and albumin in vivo by metabolites of trichloroethylene, trichloroacetate, and dichloroacetate in rats and mice. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[54]  B. L. Duuren,et al.  Carcinogenicity of halogenated olefinic and aliphatic hydrocarbons in mice. , 1979, Journal of the National Cancer Institute.

[55]  R. Bull,et al.  Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetate. , 1990, Toxicology.

[56]  P. Åstrand,et al.  Textbook of Work Physiology , 1970 .

[57]  Dale Hattis,et al.  Improvements in Quantitative Noncancer Risk Assessment , 1993 .

[58]  B C Allen,et al.  Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[59]  L. Lash,et al.  Metabolic activation and detoxication of nephrotoxic cysteine and homocysteine S-conjugates. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Thomas Brüning,et al.  Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. , 2003, American journal of industrial medicine.

[61]  R. Jirtle,et al.  Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. , 1991, Progress in clinical and biological research.

[62]  T. Goldsworthy,et al.  Potential role of alpha-2 mu-globulin, protein droplet accumulation, and cell replication in the renal carcinogenicity of rats exposed to trichloroethylene, perchloroethylene, and pentachloroethane. , 1988, Toxicology and applied pharmacology.

[63]  K S Crump,et al.  An improved procedure for low-dose carcinogenic risk assessment from animal data. , 1984, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[64]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[65]  H. Barton,et al.  Dichloroacetic acid: metabolism in cytosol. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[66]  R. Bull,et al.  Induction of strand breaks in DNA by trichloroethylene and metabolites in rat and mouse liver in vivo. , 1988, Toxicology and applied pharmacology.

[67]  R. Maronpot,et al.  ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. , 1994, Carcinogenesis.

[68]  J W Fisher,et al.  A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. , 1998, Toxicology and applied pharmacology.

[69]  J. Fisher,et al.  Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. , 1999, Journal of toxicology and environmental health. Part A.

[70]  J. Mills,et al.  Effect of cadmium on F-actin and microtubules of Madin-Darby canine kidney cells. , 1989, Toxicology and applied pharmacology.

[71]  I. Schultz,et al.  Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. , 1997, Toxicology and applied pharmacology.

[72]  H. Bolt,et al.  Reactive metabolites and carcinogenicity of halogenated ethylenes. , 1982, Biochemical pharmacology.

[73]  G. Olson,et al.  Failure of monochloroacetic acid and trichloroacetic acid administered in the drinking water to produce liver cancer in male F344/N rats. , 1997, Journal of toxicology and environmental health.

[74]  J. Högberg,et al.  Three industrial solvents investigated for tumor promoting activity in the rat liver. , 1987, Cancer letters.

[75]  M. W. Anders,et al.  Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. , 1986, Biochemical pharmacology.

[76]  D. Putt,et al.  Glutathione conjugation of trichloroethylene in rats and mice: sex-, species-, and tissue-dependent differences. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[77]  D. House,et al.  Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. , 1999, Journal of toxicology and environmental health. Part A.

[78]  Dedrick Rl,et al.  Pharmacokinetic and pharmacodynamic considerations for chronic hemodialysis. , 1975, Kidney international. Supplement.

[79]  P A Stewart,et al.  Retrospective cohort mortality study of workers at an aircraft maintenance facility. II. Exposures and their assessment. , 1991, British journal of industrial medicine.

[80]  A. Koizumi Potential of physiologically based pharmacokinetics to amalgamate kinetic data of trichloroethylene and tetrachloroethylene obtained in rats and man. , 1989, British journal of industrial medicine.

[81]  B. Thrall,et al.  Dichloroacetate stimulates glycogen accumulation in primary hepatocytes through an insulin-independent mechanism. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[82]  J. Larson,et al.  Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. , 1992, Toxicology and applied pharmacology.

[83]  D W Potter,et al.  A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. , 1992, Toxicology and applied pharmacology.

[84]  A. Owens,et al.  Further studies on the metabolic fate of chloral hydrate and trichloroethanol. , 1955, Bulletin of the Johns Hopkins Hospital.

[85]  R J Bull,et al.  Physiologically-based pharmacokinetic model for trichloroethylene considering enterohepatic recirculation of major metabolites. , 1998, Risk analysis : an official publication of the Society for Risk Analysis.

[86]  P A Stewart,et al.  Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. , 1991, British journal of industrial medicine.

[87]  K. Nomiyama,et al.  Dose-response relationship for trichloroethylene in man , 1977, International archives of occupational and environmental health.

[88]  J. Boice,et al.  Mortality among aircraft manufacturing workers. , 1999, Occupational and environmental medicine.

[89]  Jack A. Taylor,et al.  Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. , 1994, Pharmacogenetics.

[90]  B. Merrick,et al.  Differing hepatotoxicity and lethality after subacute trichloroethylene exposure in aqueous or corn oil gavage vehicles in B6C3F1 Mice , 1989, Journal of applied toxicology : JAT.

[91]  J. Peters,et al.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.

[92]  J. Manson,et al.  Effects of oral exposure to trichloroethylene on female reproductive function. , 1984, Toxicology.

[93]  M. Templin,et al.  The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene. , 1993, Toxicology letters.

[94]  R. T. Miller,et al.  Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis. , 1994, Progress in clinical and biological research.

[95]  H J Clewell,et al.  Biologically motivated models for chemical risk assessment. , 1989, Health physics.

[96]  G. Williams,et al.  Saccharin mechanistic data and risk assessment: urine composition, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.

[97]  R. Conolly,et al.  A 90-day chloroform inhalation study in female and male B6C3F1 mice: implications for cancer risk assessment. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[98]  M. Templin,et al.  Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. , 1993, Toxicology and applied pharmacology.

[99]  D Henschler,et al.  Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethene exposure in humans: implications for the risk of trichloroethene exposure. , 1993, Environmental health perspectives.

[100]  B. Lake,et al.  Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset. , 1989, Toxicology and applied pharmacology.

[101]  P Grasso,et al.  Hepatic peroxisome proliferation in rodents and its significance for humans. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[102]  I. Schultz,et al.  The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. , 1998, Toxicological sciences : an official journal of the Society of Toxicology.

[103]  P O Droz,et al.  Variability in biological monitoring of solvent exposure. I. Development of a population physiological model. , 1989, British journal of industrial medicine.

[104]  R L Dedrick Pharmacokinetic and pharmacodynamic considerations for chronic hemodialysis. , 1975, Kidney international. Supplement.

[105]  A. Deangelo,et al.  Species and strain sensitivity to the induction of peroxisome proliferation by chloroacetic acids. , 1989, Toxicology and applied pharmacology.

[106]  H J Clewell,et al.  Applying simulation modeling to problems in toxicology and risk assessment--a short perspective. , 1995, Toxicology and applied pharmacology.

[107]  H J Clewell,et al.  Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1989, Toxicology and applied pharmacology.

[108]  J. Opdam Intra and interindividual variability in the kinetics of a poorly and highly metabolising solvent. , 1989, British journal of industrial medicine.

[109]  C B Frederick,et al.  Limiting the uncertainty in risk assessment by the development of physiologically based pharmacokinetic and pharmacodynamic models. , 1993, Toxicology letters.

[110]  T. Lawlor,et al.  Absence of mutagenic effects of sodium dichloroacetate. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[111]  S. Curry,et al.  Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses , 1991, Biopharmaceutics & drug disposition.

[112]  R C Spear,et al.  Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.

[113]  H. Bolt Pharmacokinetic factors and their implication in the induction of mouse liver tumors by halogenated hydrocarbons. , 1987, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[114]  T. Nakajima,et al.  Three forms of trichloroethylene-metabolizing enzymes in rat liver induced by ethanol, phenobarbital, and 3-methylcholanthrene. , 1990, Toxicology and applied pharmacology.

[115]  NTP Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin) (CAS No. 79-01-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). , 1990, National Toxicology Program technical report series.

[116]  Timothy R. Gerrity,et al.  Principles of route-to-route extrapolation for risk assessment : proceedings of the Workshops on Principles of Route-to-Route Extrapolation for Risk Assessment held March 19-21, 1990, in Hilton Head, South Carolina and July 10-11, 1990, in Durham, North Carolina , 1990 .

[117]  F Y Bois,et al.  Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.

[118]  M. A. Pereira,et al.  Carcinogenic activity of dichloroacetic acid and trichloroacetic acid in the liver of female B6C3F1 mice. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[119]  M. A. Pereira,et al.  Promotion by dichloroacetic acid and trichloroacetic acid of N-methyl-N-nitrosourea-initiated cancer in the liver of female B6C3F1 mice. , 1996, Cancer letters.

[120]  M S Prout,et al.  Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. , 1985, Toxicology and applied pharmacology.

[121]  P O Droz,et al.  Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model. , 1989, British journal of industrial medicine.

[122]  A. J. Gandolfi,et al.  Chronic toxicity of S‐(trans‐1,2‐dichlorovinyl)‐L‐cysteine in mice , 1984, Journal of applied toxicology : JAT.

[123]  J. Fisher,et al.  Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models. A two-compartment description. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[124]  S. Okuyama,et al.  Ethanol-induced enhancement of trichloroethylene metabolism and hepatotoxicity: difference from the effect of phenobarbital. , 1988, Toxicology and applied pharmacology.

[125]  P. Stacpoole The pharmacology of dichloroacetate. , 1989, Metabolism: clinical and experimental.

[126]  D. Stevens,et al.  Acid-labile adducts to protein can be used as indicators of the cysteine S-conjugate pathway of trichloroethene metabolism. , 1995, Journal of toxicology and environmental health.

[127]  C. Maltoni,et al.  Long‐Term Carcinogenicity Bioassays on Trichloroethylene Administered by Inhalation to Sprague‐Dawley Rats and Swiss and B6C3F1 Mice , 1988, Annals of the New York Academy of Sciences.

[128]  N. Vermeulen,et al.  Mutagenicity and cytotoxicity of two regioisomeric mercapturic acids and cysteine S-conjugates of trichloroethylene , 2005, Archives of Toxicology.

[129]  M E Andersen,et al.  Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. , 1991, Toxicology and applied pharmacology.

[130]  S H Khan,et al.  Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[131]  D. Stevens,et al.  Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. , 1996, Toxicology.

[132]  C. Elcombe,et al.  Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity. , 1985, Toxicology and applied pharmacology.

[133]  H J Clewell,et al.  Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. , 1995, Chemosphere.

[134]  J. Brown,et al.  Enhancement of the hepatotoxicity of chloroform in B6C3F1 mice by corn oil: implications for chloroform carcinogenesis. , 1986, Environmental health perspectives.

[135]  H Tsuruta,et al.  Inhalation carcinogenicity of trichloroethylene in mice and rats. , 1983, Industrial health.

[136]  J. Styles,et al.  Trichloroacetic acid: studies on uptake and effects on hepatic DNA and liver growth in mouse. , 1991, Carcinogenesis.

[137]  P Fenner-Crisp,et al.  Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? , 1998, Regulatory toxicology and pharmacology : RTP.

[138]  S. Curry,et al.  Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate , 1985, Clinical pharmacology and therapeutics.

[139]  G. Johanson,et al.  Effects of consumption of ethanol on the biological monitoring of exposure to organic solvent vapours: a simulation study with trichloroethylene. , 1991, British journal of industrial medicine.

[140]  C. Elcombe Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene: a biochemical human hazard assessment. , 1985, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[141]  D. DeMarini,et al.  Dichloroacetic acid and related compounds: induction of prophage in E. coli and mutagenicity and mutation spectra in Salmonella TA100. , 1994, Mutagenesis.

[142]  P. Bonate,et al.  Factors affecting species differences in the kinetics of metabolites of trichloroethylene. , 1995, Journal of toxicology and environmental health.

[143]  I. Davidson,et al.  Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. , 1991, Drug metabolism reviews.

[144]  N. Lalwani,et al.  Induction of hepatic peroxisome proliferation in nonrodent species, including primates. , 1984, The American journal of pathology.

[145]  O. Axelson,et al.  Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. , 1994, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[146]  A J Bailer,et al.  The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[147]  L. Lash,et al.  Mechanism of S-(1,2-dichlorovinyl)-L-cysteine- and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity. , 1987, Molecular pharmacology.

[148]  R W D'Souza,et al.  Physiological Pharmacokinetic Models: Some Aspects of Theory, Practice and Potential , 1988, Toxicology and industrial health.

[149]  J. Opdam Respiratory input in inhalation experiments. , 1989, British journal of industrial medicine.

[150]  H. Bartsch,et al.  Comparison of the hydroxylation of benzo(a)pyrene with the metabolism of vinyl chloride, N-nitrosomorpholine, and N-nitroso-N'-methylpiperazine to mutagens by human and rat liver microsomal fractions. , 1980, Cancer research.

[151]  P. Eacho,et al.  Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. , 1990, Toxicology and applied pharmacology.

[152]  J. Odum,et al.  Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans. , 1990, Toxicology and applied pharmacology.

[153]  M E Andersen,et al.  Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling. , 1990, Toxicology and applied pharmacology.

[154]  J. Larson,et al.  Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. , 1992, Toxicology and applied pharmacology.

[155]  H. Moch,et al.  [Analysis of kidney tumors in trichloroethylene exposed workers by comparative genomic hybridization and DNA sequence analysis]. , 1999, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[156]  H J Clewell,et al.  Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. , 2001, The Science of the total environment.

[157]  L. Rhomberg Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals. , 2000, Environmental health perspectives.

[158]  S. Nasim,et al.  Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. , 1995, Carcinogenesis.

[159]  R. Kanamaru,et al.  Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung Cancer , 1991, Japanese journal of cancer research : Gann.

[160]  H. Brauch,et al.  Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. , 1999, Journal of the National Cancer Institute.

[161]  Julia S Kimbell,et al.  Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[162]  Richard D. Thomas Dose-Route Extrapolations: Using Inhalation Toxicity Data to Set Drinking Water Limits , 1986 .

[163]  H. Vainio,et al.  A comparative study on the contribution of cytochrome P450 isozymes to metabolism of benzene, toluene and trichloroethylene in rat liver. , 1992, Biochemical pharmacology.

[164]  D. Henschler,et al.  Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species , 1980, Archives of Toxicology.

[165]  B. Allen,et al.  Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output. , 1989, Toxicology letters.

[166]  H W Leung,et al.  Development and utilization of physiologically based pharmacokinetic models for toxicological applications. , 1991, Journal of toxicology and environmental health.

[167]  Ulrike Bernauer,et al.  Biotransformation of trichloroethene: dose-dependent excretion of 2,2,2-trichloro-metabolites and mercapturic acids in rats and humans after inhalation , 1996, Archives of Toxicology.

[168]  A. Blackburn,et al.  Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. , 2000, Chemical research in toxicology.

[169]  D. Casciano,et al.  Mouse liver microsomal metabolism of chloral hydrate, trichloroacetic acid, and trichloroethanol leading to induction of lipid peroxidation via a free radical mechanism. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[170]  I. S. Blagbrough,et al.  Human renal C-S lyase: structure-activity relationships of cytosolic and mitochondrial enzymes. , 1990, Toxicology letters.

[171]  D. Henschler,et al.  Metabolism of trichloroethylene in man , 2004, Archives of Toxicology.

[172]  A. Owens,et al.  Absorption, excretion and metabolic fate of chloral hydrate and trichloroethanol. , 1954, Bulletin of the Johns Hopkins Hospital.

[173]  D. Stevens,et al.  Renal activation of trichloroethene and S-(1,2-dichlorovinyl)-L-cysteine and cell proliferative responses in the kidneys of F344 rats and B6C3F1 mice. , 1995, Journal of toxicology and environmental health.

[174]  R. Snyder,et al.  In vivo administration of dichloroacetic acid suppresses spontaneous apoptosis in murine hepatocytes. , 1995, Cancer research.

[175]  R H Reitz,et al.  Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations. , 1988, Toxicology and applied pharmacology.

[176]  R. Bull,et al.  Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA). , 1997, Toxicology and applied pharmacology.

[177]  A. Steinberg,et al.  Have animal data been used inappropriately to estimate risks to humans from environmental trichloroethylene? , 1993, Regulatory toxicology and pharmacology : RTP.

[178]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[179]  W. Stott,et al.  The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats. , 1982, Toxicology and applied pharmacology.

[180]  E. Lock Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes. , 1988, Critical reviews in toxicology.

[181]  S Kettle,et al.  Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.

[182]  A. Monster,et al.  Pharmacokinetics of trichloroethylene in volunteers, influence of workload and exposure concentration , 1976, International archives of occupational and environmental health.

[183]  Gary M Williams,et al.  Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and livermitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL6N and BALBc mice , 1992 .

[184]  I. Schultz,et al.  Effect of pre-treatment with dichloroacetic or trichloroacetic acid in drinking water on the pharmacokinetics of a subsequent challenge dose in B6C3F1 mice. , 1999, Chemico-biological interactions.

[185]  D. Stevens,et al.  Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. , 1996, Journal of analytical toxicology.

[186]  J. Reddy,et al.  Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. , 1983, Critical reviews in toxicology.

[187]  J. Buben,et al.  Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene: a dose-effect study. , 1985, Toxicology and applied pharmacology.

[188]  T. Brüning,et al.  Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene. , 1999, Occupational medicine.

[189]  W. Dekant,et al.  Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. , 1988, Chemical research in toxicology.

[190]  J. Lipscomb,et al.  Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. , 1997, Toxicology and applied pharmacology.

[191]  Richard D. Thomas Drinking Water and Health , 1986 .

[192]  D. Wolf,et al.  Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice. , 1993, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[193]  T. Green Species differences in carcinogenicity: the role of metabolism in human risk evaluation. , 1990, Teratogenesis, carcinogenesis, and mutagenesis.

[194]  J. N. Blancato,et al.  Update to the health assessment document and addendum for dichloromethane (methylene chloride): pharmacokinetics, mechanism of action, and epidemiology. External review draft , 1987 .

[195]  D. Wolf,et al.  Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: comparison of administration by gavage in corn oil vs ad libitum in drinking water. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[196]  R. Bull,et al.  Dichloroacetic acid and trichloroacetic acid-induced DNA strand breaks are independent of peroxisome proliferation. , 1989, Toxicology.

[197]  M. Metzler,et al.  Absorption, elimination and metabolism of trichloroethylene: a quantitative comparison between rats and mice. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.

[198]  D. Mayers,et al.  Chloral hydrate disposition following single-dose administration to critically ill neonates and children. , 1991, Developmental pharmacology and therapeutics.

[199]  A. Deangelo,et al.  The role of hyperplastic nodules in dichloroacetic acid-induced hepatocarcinogenesis in B6C3F1 male mice. , 1991, Carcinogenesis.

[200]  J. M. Christensen,et al.  Urinary concentrations of trichloroacetic acid in Danish workers exposed to trichloroethylene, 1947-1985. , 2001, American journal of industrial medicine.

[201]  K. Ivanetich,et al.  Chlorinated ethylenes: their metabolism and effect on DNA repair in rat hepatocytes. , 1984, Carcinogenesis.

[202]  D. Henschler,et al.  Carcinogenicity study of trichloroethylene, with and without epoxide stabilizer, in mice , 2005, Journal of Cancer Research and Clinical Oncology.

[203]  J. Blancato,et al.  Metabolism, toxicity, and carcinogenicity of trichloroethylene. , 1989, Critical reviews in toxicology.

[204]  E. Mariman,et al.  The insulin–like growth factor type–2 receptor gene is imprinted in the mouse but not in humans , 1993, Nature Genetics.

[205]  M. Ellis,et al.  The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. , 1997, Chemico-biological interactions.

[206]  Brian A. Wong,et al.  A 90-day chloroform inhalation study in F-344 rats: profile of toxicity and relevance to cancer studies. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[207]  G. Olson,et al.  Carcinogenicity of Chloral Hydrate Administered in Drinking Water to the Male F344/N Rat and Male B6C3F1 Mouse , 2000, Toxicologic pathology.

[208]  Jirtle Rl Liver tumor promotion: a process of natural selection. , 1995 .

[209]  E. R. Garrett,et al.  Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters. , 1973, Journal of pharmaceutical sciences.

[210]  Yu-Mei Tan,et al.  Biologically motivated computational modeling of chloroform cytolethality and regenerative cellular proliferation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[211]  J. H. Carter,et al.  Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F344) rats. , 1995, Cancer letters.

[212]  H J Clewell,et al.  Coupling of computer modeling with in vitro methodologies to reduce animal usage in toxicity testing. , 1993, Toxicology letters.

[213]  E. Heseltine,et al.  Dry cleaning, some solvents used in dry cleaning and other industrial chemicals. IARC meeting, Lyon, 7-14 February 1995. , 1995, Scandinavian journal of work, environment & health.

[214]  J. Fisher,et al.  Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. , 1999, Toxicology and applied pharmacology.

[215]  M E Meek,et al.  Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[216]  K T Bogen,et al.  Pharmacokinetics for regulatory risk analysis: the case of trichloroethylene. , 1988, Regulatory toxicology and pharmacology : RTP.

[217]  J W Fisher,et al.  A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. , 1997, Toxicology and applied pharmacology.

[218]  J. Odum,et al.  A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. , 1992, Chemico-biological interactions.

[219]  G. Lucier,et al.  Considerations concerning the murine hepatocarcinogenicity of selected chlorinated hydrocarbons. , 1995, Progress in clinical and biological research.

[220]  J. Auwerx,et al.  Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient Mice* , 1997, The Journal of Biological Chemistry.

[221]  W. Dekant,et al.  Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates. , 1987, Biochemical pharmacology.

[222]  H. Vainio,et al.  Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes. , 1993, Biochemical pharmacology.

[223]  G. Olson,et al.  The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[224]  M. Metzler,et al.  Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans. , 1984, Biochemical pharmacology.

[225]  R. T. Miller,et al.  TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion. , 1995, Carcinogenesis.

[226]  R J Bull,et al.  Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. , 1990, Toxicology.

[227]  T. Green,et al.  Chloroethylenes: a mechanistic approach to human risk evaluation. , 1990, Annual review of pharmacology and toxicology.

[228]  D. Savitz,et al.  Magnetic Field Exposure and Neurodegenerative Disease Mortality among Electric Utility Workers , 1998, Epidemiology.

[229]  R. Coulombe,et al.  Pharmacokinetics in Risk Assessment , 1996 .

[230]  D. H. Taylor,et al.  Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. , 1990, Toxicology and applied pharmacology.

[231]  D. Waxman,et al.  Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. , 1998, Environmental health perspectives.

[232]  F Y Bois,et al.  Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans. , 1990, Toxicology and applied pharmacology.

[233]  R. Hertzberg,et al.  A new method for determining allowable daily intakes. , 1986, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[234]  K. H. Vyas,et al.  Biological disposition of sodium dichloroacetate in animals and humans after intravenous administration. , 1980, Journal of pharmaceutical sciences.

[235]  F Y Bois,et al.  Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.

[236]  B. Thrall,et al.  Effects of dichloroacetate (DCA) on serum insulin levels and insulin-controlled signaling proteins in livers of male B6C3F1 mice. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[237]  M. Metzler,et al.  Identification of S-1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats. , 1986, Biochemical pharmacology.

[238]  P. Newberne,et al.  Effects of dietary fat on hepatic mixed-function oxidases and hepatocellular carcinoma induced by aflatoxin B1 in rats. , 1979, Cancer research.

[239]  J. Gallo,et al.  Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. , 1991, Toxicology and applied pharmacology.

[240]  B. Gonthier,et al.  In-vitro spin-trapping of free radicals produced during trichloroethylene and diethylether metabolism. , 1989, Toxicology letters.

[241]  H J Clewell,et al.  Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). , 1993, Toxicology letters.

[242]  G. Williams,et al.  Butylated hydroxyanisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion. , 1996, Pharmacology & therapeutics.

[243]  Rory B. Conolly,et al.  Physiologically Based Pharmacokinetic Model of the Metabolism of Trichloroethylene by an Isolated Ventilated Perfused Lung , 1990 .

[244]  H J Clewell,et al.  Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzene. , 1994, Risk analysis : an official publication of the Society for Risk Analysis.

[245]  M E Hurtt,et al.  Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. , 1992, Toxicology and applied pharmacology.

[246]  G. Olson,et al.  The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. , 1996, Toxicology.

[247]  S. Bondy,et al.  Ethanol toxicity and oxidative stress. , 1992, Toxicology letters.

[248]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[249]  D E Marano,et al.  Exposure assessment for a large epidemiological study of aircraft manufacturing workers. , 2000, Applied occupational and environmental hygiene.

[250]  K. Hemminki,et al.  Cancer Incidence among Finnish Workers Exposed to Halogenated Hydrocarbons , 1995 .

[251]  Kannan Krishnan,et al.  Incorporation of Pharmacokinetic and Pharmacodynamic Data into Risk Assessments , 2004, Toxicology mechanisms and methods.

[252]  M. Kelsh,et al.  Mortality of Aerospace Workers Exposed to Trichloroethylene , 1998, Epidemiology.

[253]  A Sato,et al.  The effect of environmental factors on the pharmacokinetic behaviour of organic solvent vapours. , 1991, The Annals of occupational hygiene.

[254]  G. Johanson,et al.  A simulation study of physiological factors affecting pharmacokinetic behaviour of organic solvent vapours. , 1991, British journal of industrial medicine.

[255]  G. L. Kedderis,et al.  The role of regenerative cell proliferation in chloroform-induced cancer. , 1995, Toxicology letters.

[256]  D. Stevens,et al.  Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[257]  W. Dekant,et al.  Biosynthesis and biotransformation of glutathione S-conjugates to toxic metabolites. , 1988, Critical reviews in toxicology.